The Rare Double Upgrade: Why Morgan Stanley Loves AstraZeneca After Hating It
December 01, 2015 at 14:13 PM EST
On Tuesday, analysts at Morgan Stanley took a look at AstraZeneca plc (ADR) (NYSE: AZN) as it starts to reap the benefits of the ...